Evaluation of Myeloid-derived Suppressor Cells in the Blood of Iranian COVID-19 Patients. (2022)
Attributed to:
MICA: Korea-UK PRISM consortium: Establishing Precision Medicine in severe asthma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18502/ijaai.v21i4.10294
PubMed Identifier: 36243935
Publication URI: http://europepmc.org/abstract/MED/36243935
Type: Journal Article/Review
Volume: 21
Parent Publication: Iranian journal of allergy, asthma, and immunology
Issue: 4
ISSN: 1735-1502